Clinical evaluation of a plasma Neurofilament Light chain electrochemiluminescence immunoassay in Alzheimer’s disease

Hadia A Fatima, Nikhil Padmanabhan, Rachel Cohen, Daniel Romero, Catherine Demos, Jacob N Wohlstadter, George Sigal, Steven E Arnold, Pia Kivisäkk · 2025

Read Clinical evaluation of a plasma Neurofilament Light chain electrochemiluminescence immunoassay in Alzheimer’s disease by Hadia A Fatima, Nikhil Padmanabhan, Rachel Cohen, Daniel Romero, Catherine Demos, Jacob N Wohlstadter, George Sigal, Steven E Arnold, Pia Kivisäkk (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715226.txt.

Description

Fatima and co-authors test a blood test for a protein that leaks from damaged nerve fibers, in people with Alzheimer disease and related conditions. Their 2025 study uses stored blood from 541 people in a long-running Boston cohort. The group held 262 people with Alzheimer disease, others with different brain diseases, and 112 healthy controls.

Levels from the new test matched a rival test closely in a smaller group. People with non-Alzheimer brain diseases had the highest levels, followed by the Alzheimer group. Higher levels also tracked worse thinking scores at the time of the blood draw. Among people with mild problems at the start, higher levels marked those whose thinking worsened over four years. The test may help both in care and in trials.

Catalog record

CREATORHadia A Fatima, Nikhil Padmanabhan, Rachel Cohen, Daniel Romero, Catherine Demos, Jacob N Wohlstadter, George Sigal, Steven E Arnold, Pia Kivisäkk
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11715226

Browse the full library · About the Tower of Babel